منابع مشابه
Clinical pharmacology = disease progression + drug action.
Clinical pharmacology is concerned with understanding how to use medicines to treat disease. Pharmacokinetics and pharmacodynamics have provided powerful methodologies for describing the time course of concentration and effect in individuals and in populations. This population approach may also be applied to describing the progression of disease and the action of drugs to change disease progres...
متن کاملManaging Drug Toxicities & Drug Interactions: Clinical Pharmacology Case-based Discussion
Introduction A drug interaction occurs when one drug alters the pharmacological effect (enhanced or decreased) of another drug. In human medicine there are several resources available to screen for drug interactions, and there are specific guidelines and agencies to report suspected drug interactions to. In veterinary medicine screening, monitoring, and reporting of drug interactions are rarely...
متن کاملClinical drug development--practical issues in clinical pharmacology studies.
INTRODUCTION Clinical pharmacology refers to the study of the safety, pharmacodynamic activity, mechanism of action, pharmacokinetics, metabolism and excretion of a drug in man. METHODS Selected review of topics that provide guidance on practical issues for researchers conducting non-therapeutic investigational research in humans. RESULTS Close attention to the issues highlighted is needed ...
متن کاملClinical pharmacology--an electronic drug reference and teaching guide.
The Bulletin of the Medical Library Association (ISSN: 0025-7338) is published four times a year, in January, April, July, and October, by the Medical Library Association, Suite 300, Six North Michigan Avenue, Chicago, IL 60602-4805. 1995 subscription rates: $136.00/year, United States, Canada, Mexico; $174.00/year, all other regions. A limited number of single back issues are available for $42...
متن کاملPharmacology and Clinical Drug Candidates in Redox Medicine
SIGNIFICANCE Oxidative stress is suggested to be a disease mechanism common to a wide range of disorders affecting human health. However, so far, the pharmacotherapeutic exploitation of this, for example, based on chemical scavenging of pro-oxidant molecules, has been unsuccessful. RECENT ADVANCES An alternative emerging approach is to target the enzymatic sources of disease-relevant oxidativ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Clinical Pharmacology
سال: 1999
ISSN: 0306-5251,1365-2125
DOI: 10.1046/j.1365-2125.1999.00907.x